Of the patients with missing pre-treatment CD4+ T-cell counts, 46% had a documented AIDS-defining clinical condition 90-days prior to or 30-days post initiating ART compared to 32% of those with a pre-treatment CD4+ T-cell count. The gene discussed is CD4; the disease is AIDS.